Clinical Trials

28 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07030283 2026-02-02

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Phase 1 Recruiting

10 enrolled

Gynecologic

Neoplasm Metastasis, Peritoneal Neoplasms

NCT06320405 2025-12-29

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

38 enrolled

Phase 1 Active not recruiting

Neoplasm Metastasis

NCT06107868 2025-12-08

GyneRep

6 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Uterine Neoplasms

NCT06846346 2025-11-28

GRACIE

Phase 2 Recruiting

88 enrolled

Phase 2 Active not recruiting

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT01898117 2025-11-26

Triple-B

304 enrolled

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT01187199 2025-10-27

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

278 enrolled

Phase 3 Active not recruiting

Neoplasm Metastasis

NCT04158362 2025-09-22

AMBRE

180 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02423603 2025-03-10

PAKT

71 enrolled

Phase 1/2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT02734290 2025-03-10

Standard of Care Chemotherapy Plus Pembrolizumab for Breast Cancer

29 enrolled 12 charts

Phase 1/2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03616886 2024-12-19

SYNERGY

129 enrolled

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT03921671 2024-05-29

RELEVENT

60 enrolled

Thoracic

Neoplasm Metastasis, Thymoma

NCT03841747 2024-03-12

PELICAN

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT04694183 2024-02-07

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

37 enrolled

BreastGenitourinaryGynecologic

Neoplasm Metastasis, Stomach Neoplasms

NCT04602117 2023-11-18

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Phase 1 Withdrawn

Urinary Bladder Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT01015222 2022-11-23

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies

122 enrolled

Neoplasm Metastasis

NCT02824575 2022-04-04

Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer

Phase 1 Terminated

28 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04808466 2022-02-21

WUHIPEC01

231 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT01835236 2021-03-30

Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

208 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT03887442 2021-01-07

EXTAX

Phase 2 Terminated

17 enrolled 8 charts

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT03989310 2020-12-23

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Phase 1/2 Unknown

50 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02124707 2020-08-12

Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN

14 enrolled 17 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT02628132 2020-07-07

Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients

Phase 1/2 Completed

22 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02406170 2019-10-22

REPEAT

Phase 1/2 Completed

47 enrolled

Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT04004234 2019-07-09

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Phase 1/2 Unknown

20 enrolled

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT02560038 2018-11-28

Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer

Phase 2 Terminated

3 enrolled 9 charts

Genitourinary

Urinary Bladder Neoplasms, Neoplasm Metastasis

NCT01256268 2017-08-30

Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids

24 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

NCT02474186 2017-08-03

Phase II Study for Solid Metastatic Tumors

41 enrolled

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT01108055 2017-06-09

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

43 enrolled 16 charts

Genitourinary

Urinary Bladder Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00561119 2017-05-01

Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer

Phase 3 Completed

326 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00350025 2017-03-31

Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer

41 enrolled 11 charts

Genitourinary

Neoplasm Metastasis, Neoplasms, Urologic Neoplasms

NCT02274012 2017-03-14

Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Phase 2 Withdrawn

Esophageal Neoplasms, Neoplasm Metastasis

NCT02855788 2016-08-04

Metronomic Chemotherapy in Advanced Gastric Cancer

40 enrolled

Neoplasm Metastasis, Stomach Neoplasms

NCT01069796 2016-03-17

Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast Cancer

Phase 2 Terminated

64 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02051868 2015-11-04

InterAACT

80 enrolled

Anus Neoplasms, Neoplasm Metastasis

NCT01011075 2015-07-03

6137p

34 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00176241 2015-06-08

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

Phase 1 Terminated

7 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Recurrence

NCT00731861 2014-09-11

Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors

28 enrolled